Abstract On March 23, 2022, the FDA approved Pluvicto (lutetium Lu 177 vipivotide
tetraxetan, also known as 177Lu-PSMA-617) for the treatment of adult patients with prostate …

Cancer is one of the leading causes of death worldwide due to high heterogeneity. Although
chemotherapy remains the mainstay of cancer therapy, non-selective toxicity and drug …

We demonstrated a practical and general methodology for the synthesis of secondary
trifluoromethyl boronic esters through visible light induced decarboxylative alkylation …

Purpose We aimed to compare the diagnostic performance and biodistribution of two similar
PET agents,[68Ga] Ga-P16-093 and [68Ga] Ga-PSMA-11, in the same group of primary …

Nanodiagnostics have been used in clinical diagnosis for over 60 years [1]. The
nanoparticles tend to be either intrinsically (optically or magnetically) active or labeled with …

The emergence of peptide–drug conjugates (PDCs) that utilize target-oriented peptide
moieties as carriers of cytotoxic payloads, interconnected with various cleavable …

Radiopharmaceutical therapy is an emerging treatment modality that has demonstrated
increasing importance as a significant component in the treatment of cancer. Prostate cancer …

The incidence of cancer and its subsequent morbidity and mortality are increasing
dramatically all over the world. Early diagnosis and treatment of cancer substantially …

A diagnostic test can be a clinical laboratory test in a broad term, a medical imaging device,
or a medical imaging drug. Medical imaging drugs are drugs and biological products …